Showing results (291-300 of 1,004) with videos related to

Sort By:
Pageof 101
The American Journal of Pathology|February 1, 1990
Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analysesA Pagani, M Papotti, H Höfler, et al.
Wiener Klinische Wochenschrift|August 11, 2017
General practitioners in Styria - who is willing to take part in research projects and why? : A survey by the Institute of General Practice and Health Services ResearchStephanie Poggenburg, Manuel Reinisch, Reinhild Höfler, et al.
Laryngologie, Rhinologie, Otologie|November 1, 1986
[Differences in the neuromuscular blockade of the larynx and thenar muscles following relaxation with vecuronium]W Streinzer, H Gilly, G Redl, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1987
Simultaneous localization of calcitonin mRNA and peptide in a medullary thyroid carcinomaH Höfler, B Pütz, C Ruhri, et al.
International Journal of Cancer|May 15, 1989
Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skinG Fürstenberger, M Rogers, R Schnapke, et al.
Expert Opinion on Pharmacotherapy|December 3, 2015
Pharmacologic treatment of status epilepticusEugen Trinka, Julia Höfler, Markus Leitinger, et al.
Pharmacology Research & Perspectives|August 17, 2019
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjectsKarsten Roth, Dirk Lehnick, Hendrik Wessels, et al.
Pharmacology Research & Perspectives|August 17, 2019
Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjectsHendrik Wessels, Dirk Lehnick, Josef Höfler, et al.
World Journal of Surgery|March 1, 1995
Staging gastrointestinal cancer as a precondition for multimodal treatmentJ R Siewert, A Sendler, H J Dittler, et al.
Klinische Padiatrie|August 8, 2002
[Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients]M Nathrath, M Kremer, H Letzel, et al.
Pageof 101